LRFN2 gene variant rs2494938 provides susceptibility to esophageal cancer in the population of Jammu and Kashmir

J Cancer Res Ther. 2020 Dec;16(Supplement):S156-S159. doi: 10.4103/jcrt.JCRT_613_19.

Abstract

Background: Leucine-rich repeat and fibronectin type 2 gene (LRFN2) variant rs2494938 has recently been found associated with esophageal cancer in a genome-wide association study in an Asian population. However, this association has not been replicated in any Indian population despite high incidence of the disease.

Materials and methods: In the present case-control study, 166 cases and 459 controls were included. Taqman assay technique using real-time PCR was employed to investigate the association of the variant with esophageal cancer in the population of Jammu and Kashmir (J&K). The Hardy-Weinberg equilibrium for rs2494938 was assessed using the Chi-square test. The allele- and genotype-specific risk was estimated by odds ratio (OR) with 95% confidence interval (CI).

Results: Variant rs2494938 was observed to be significantly associated with esophageal cancer with an allelic OR of 1.59 (1.23-2.04 at 95% CI, P = 0.0003).

Conclusion: The study highlights LRFN2 as a candidate gene for esophageal cancer susceptibility in the population of J&K and calls for a detailed study with a large sample size and involving more ethnic groups of India.

Keywords: Candidate gene; Jammu and Kashmir; case–control; esophageal cancer; leucine-rich repeat and fibronectin type 2; odds ratio.

MeSH terms

  • Asian People / genetics*
  • Biomarkers, Tumor / genetics*
  • Case-Control Studies
  • Esophageal Neoplasms / epidemiology*
  • Esophageal Neoplasms / genetics
  • Esophageal Neoplasms / pathology
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Humans
  • India / epidemiology
  • Male
  • Membrane Glycoproteins / genetics*
  • Middle Aged
  • Nerve Tissue Proteins / genetics*
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • LRFN2 protein, human
  • Membrane Glycoproteins
  • Nerve Tissue Proteins